全文获取类型
收费全文 | 28433篇 |
免费 | 2791篇 |
国内免费 | 1825篇 |
专业分类
耳鼻咽喉 | 405篇 |
儿科学 | 317篇 |
妇产科学 | 161篇 |
基础医学 | 2682篇 |
口腔科学 | 883篇 |
临床医学 | 3538篇 |
内科学 | 3480篇 |
皮肤病学 | 213篇 |
神经病学 | 1088篇 |
特种医学 | 1062篇 |
外国民族医学 | 6篇 |
外科学 | 2684篇 |
综合类 | 6529篇 |
现状与发展 | 7篇 |
一般理论 | 1篇 |
预防医学 | 2516篇 |
眼科学 | 686篇 |
药学 | 2933篇 |
36篇 | |
中国医学 | 2104篇 |
肿瘤学 | 1718篇 |
出版年
2024年 | 109篇 |
2023年 | 337篇 |
2022年 | 868篇 |
2021年 | 1194篇 |
2020年 | 1016篇 |
2019年 | 763篇 |
2018年 | 773篇 |
2017年 | 824篇 |
2016年 | 718篇 |
2015年 | 1248篇 |
2014年 | 1610篇 |
2013年 | 1728篇 |
2012年 | 2438篇 |
2011年 | 2603篇 |
2010年 | 1957篇 |
2009年 | 1798篇 |
2008年 | 1981篇 |
2007年 | 2013篇 |
2006年 | 1744篇 |
2005年 | 1555篇 |
2004年 | 1049篇 |
2003年 | 1048篇 |
2002年 | 860篇 |
2001年 | 686篇 |
2000年 | 543篇 |
1999年 | 343篇 |
1998年 | 199篇 |
1997年 | 173篇 |
1996年 | 125篇 |
1995年 | 113篇 |
1994年 | 92篇 |
1993年 | 42篇 |
1992年 | 41篇 |
1991年 | 41篇 |
1990年 | 30篇 |
1989年 | 32篇 |
1988年 | 36篇 |
1987年 | 32篇 |
1986年 | 23篇 |
1985年 | 20篇 |
1984年 | 16篇 |
1983年 | 11篇 |
1980年 | 11篇 |
1979年 | 26篇 |
1976年 | 13篇 |
1975年 | 11篇 |
1974年 | 12篇 |
1972年 | 14篇 |
1971年 | 11篇 |
1968年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
目的 调查并分析癌症晚期患者及家属对预前指示及预前指示所含的生命维持治疗、死亡地点、诊断告知等态度的一致性。方法 便利抽取北京市某三甲医院肿瘤科268对癌症晚期患者及家属,采用预前指示态度及终末生命意愿量表调查患者及家属对预前指示及生命维持治疗、死亡地点、诊断告知的态度。结果 59.0%的患者愿意做预前指示,有88.4%的家属愿意遵守患者制定的预前指示意愿,患者及家属对预前指示态度的一致性系数Kappa值为0.010。患者及家属对生命维持治疗、死亡地点及诊断告知态度的Kappa值分别为0.158~0.235,0.227,0.056,一致性较差。结论 癌症晚期患者及家属对预前指示态度一致性较差,家属对生命维持治疗、死亡地点、诊断告知的态度不能代表患者本人的意愿。临床医护人员应加强与患者及家属的沟通,提高患者及家属对预前指示态度的一致性。 相似文献
992.
目的研究TNF-α在小鼠叶酸诱导肾病中的致病作用及其机制。方法建立小鼠叶酸诱导肾病模型,运用抗TNF-α多克隆抗体及对照抗体干预治疗,检测小鼠血清以及肾组织中TNF-α水平,肾小管上皮细胞凋亡情况以及凋亡相关蛋白的表达水平。结果在CD1小鼠叶酸诱导肾病模型中,尿素氮水平显著升高,肾小管上皮细胞坏死和凋亡增加,小鼠血清以及肾组织中TNF-α水平显著升高,肾皮质组织中Bcl-xL表达水平显著下降,运用抗TNF-α多克隆抗体干预治疗可保持Bcl—xL在肾组织中的表达水平,减少肾小管上皮细胞凋亡,有效减轻小鼠肾功能损害。结论TNF-α在小鼠叶酸诱导肾病发病机制中具有重要作用,阻断TNF-α是治疗急性肾衰的一种潜在有效手段。 相似文献
993.
994.
目的:探讨胸腔积液中腺苷脱氨酸(ADA)的活性,为临床鉴别诊断提供依据。方法:对122例患者胸腔积液进行ADA检测,并进行比较分析。结果:结核性胸腔积液中ADA活性阳性率明显高于其他组。结论:测定胸腹水中ADA活性可用于结核性与非结核性胸腹水的鉴别诊断。 相似文献
995.
妊娠糖尿病的发生率逐年上升,其对于婴儿有诸多短期及长期不良影响.因此,提高对相关不良影响的认识非常重要,积极采取各种措施保证妊娠期间血糖控制在最佳水平有助于改善母亲及后代的健康状况,降低围产期死亡率.该文综述妊娠糖尿病对婴儿的不良影响,包括巨大儿、呼吸系统疾病、代谢异常及先天畸形等. 相似文献
996.
Gang Ren Heng Yun Xiang Zhi Cheng Hu Rong Hua Liu Wen Fang Yi Jia Bing Peng 《Pharmaceutical biology》2014,52(8):944-950
Context: Searching for polymorphonuclear neutrophils (PMNs) respiratory burst inhibitors is an important topic in the treatment of human diseases associated with inflammation.Objective: To investigate the inhibitory effects of phenolics isolated from Artocarpus styracifolius Pierre (Moraceae) on respiratory burst induced by phorbol myristate acetate (PMA).Materials and methods: The anti-respiratory burst activities of eight phenolics (20?µM) were assessed by determining luminol-dependent chemiluminiscence in rat PMNs. Cytotoxicity of active compounds (1–1000?µM) was assayed by Trypan blue dye exclusion method. Cell-free models were employed to evaluate scavenging capacity of active compounds (20?µM) against reactive oxygen species.Results: The PMA-induced respiratory burst was significantly inhibited (p?0.05) by six isoprenylated phenolics (AS1–6) at the concentration of 20?µM (below the toxic concentration) with the inhibition rate ranging from 25.0 to 99.6%. The inhibitory potency estimated by IC50 was in the order of AS1 (3.1?µM) >AS6 (5.9?µM) >AS2 (9.1?µM) >AS3 (10.0?µM) >AS5 (29.7?µM) >AS4 (57.7?µM). AS1–4, four isoprenylated flavones, potently quenched superoxide anion, hydroxyl radical, and hydrogen peroxide at the concentration of 20?µM with their scavenging rates in the range of 30.1–78.1%, 35.4–69.7%, and 65.5–86.3%, respectively. In contrast, AS5–6, two isoprenylated 2-arylbenzofurans, showed less effect than that exhibited by AS1–4.Conclusion and discussion: The isoprenylated phenolics from A. styracifolius can potently inhibit PMA-induced respiratory burst in rat neutrophils without showing cytotoxicity. The inhibitory effects of these isoprenylated phenolics on the respiratory burst might depend on their different types of structure. 相似文献
997.
998.
Background
Laparoscopic splenectomy (LS) is considered as the gold standard procedure for patients with immune thrombocytopenia (ITP). In many institutions, platelet counts less than 10 × 109/L contraindicate LS.Objective
This study aimed to investigate the safety and feasibility of LS for ITP patients with platelet counts less than 10 × 109/L.Methods
A total of 88 cases of LS were performed for ITP patients from June 2010 to December 2012. The patients were prospectively divided into three groups based on their immediate preoperative platelet count: < 10 × 109/L (group 1); 10 × 109/L to 30 × 109/L (group 2); and > 30 × 109/L (group 3). We collected the patients’ demographic characteristics, perioperative details, and platelet count response to surgery.Results
The patients in the three groups had comparable demographic characteristics. Only one patient in group 1 required conversion (2.4 %). The patients in group 1 experienced more blood loss than those in group 3, but this was not statistically significant. There were no significant differences between group 2 and group 3 in terms of operating time and blood loss. No statistically significant differences were found between the three groups with regard to complications and postoperative hospital stay.Conclusions
It is safe and feasible to perform LS in ITP patients with platelet count less than 10 × 109/L, without platelet transfusion. The indication for platelet transfusion during LS for ITP patients should be the bleeding manifestations due to thrombocytopenia other than low platelet count itself. 相似文献999.
1000.